Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma
Tomography · 2025
DOI: 10.3390/tomography11060064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2025. Verfasst von Faris Durmo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences/Division of Radiology, Lund University, SE-221 00 Lund, Sweden. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Brain Neoplasms, Tumor Suppressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, ALF regional research fund, Swedish Cancer Society.
Abstract (Originalsprache)
Objectives
To assess amide proton transfer weighted (APTw) MR imaging capabilities in differentiating high-grade glial tumors across alpha-thalassemia/mental retardation X-linked (ATRX) expression, tumor-suppressor protein p53 expression (p53), O6-methylguanine-DNA methyltransferase promoter (MGMTp) methylation, isocitrate dehydrogenase (IDH) status, and proliferation marker Ki-67 (Ki-67 index) as a preoperative diagnostic aid. Material & Methods: A total of 42 high-grade glioma WHO grade 4 (HGG) patients were evaluated prospectively (30 males and 12 females). All patients were examined using conventional MRI, including the following: T1w-MPRAGE pre- and post-contrast administration, conventional T2w and 3D FLAIR, and APTw imaging with a 3T MR scanner. Receiver operating characteristic (ROC) curves were calculated for the APTw% mean, median, and max signal for the different molecular biomarkers. A logistic regression model was constructed for combined mean and median APTw% signals for p53 expression.
Results
The whole-tumor max APTw% signal could significantly differentiate MGMTp from non-MGMTp HGG, p = 0.035. A cutoff of 4.28% max APTw% signal yielded AUC (area under the curve) = 0.702, with 70.6% sensitivity and 66.7% specificity. The mean/median APTw% signals differed significantly in p53 normal versus p53-overexpressed HGG s: 1.81%/1.83% vs. 1.15%/1.18%, p = 0.002/0.006, respectively. Cutoffs of 1.25%/1.33% for the mean/median APTw% signals yielded AUCs of 0.786/0.757, sensitivities of 76.9%/76.9%, and specificities of 50%/66.2%, p = 0.002/0.006, respectively. A logistic regression model with a combined mean and median APTw% signal for p53 status yielded an AUC = 0.788 and 76.9% sensitivity and 66.2% specificity. ATRX-, IDH- wild type (wt) vs. mutation (mut), and the level of Ki-67 did not differ significantly, but trends were found: IDH-wt and low Ki-67 showed higher mean/median/max APTw% signals vs. IDH-mut and high Ki-67, respectively. ATRX-wt vs. mutation showed higher mean and median APTw% signals but lower max APTw% signal.
Conclusions
APTw imaging can potentially be a useful marker for the stratification of p53 expression and MGMT status in high-grade glioma in the preoperative setting and potentially aid surgical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences/Division of Radiology, Lund University, SE-221 00 Lund, Sweden.
- Department of Medical Imaging and Physiology, Skåne University Hospital, SE-221 85 Lund, Sweden.
- Department of Clinical Sciences/Division of Neurology, Lund University, SE-221 00 Lund, Sweden.
- Department of Clinical Sciences/Division of Pathology, Lund University, SE-221 00 Lund, Sweden.
- Advanced Systems, Magnetic Resonance, G, 91052 Erlangen, Germany.
- Department of Clinical Sciences/Division of Neurosurgery, Kamprad Laboratory, Lund University, SE-221 00 Lund, Sweden.
ORCID-Profile: Faris Durmo, Anna Rydelius, Elisabet Englund, Tim Salomonsson, Patrick Liebig, Linda Knutsson, Pia C Sundgren
Förderung
- Swedish Research Council
- ALF regional research fund
- Swedish Cancer Society
- The Swedish Childhood Cancer Foundation
- The Fru Berta Kamprad Foundation
- Regional Research Funds
Zitieren
APA
Durmo, F., Lätt, J., Rydelius, A., Englund, E., Salomonsson, T., Liebig, P., Bengzon, J., van Zijl, P. C. M., Knutsson, L., & Sundgren, P. C. (2025). Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma. Tomography. https://doi.org/10.3390/tomography11060064
Vancouver
Durmo F, Lätt J, Rydelius A, Englund E, Salomonsson T, Liebig P, et al. Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma. Tomography. 2025. doi:10.3390/tomography11060064
BibTeX
@article{Durmo2025,
author = {Durmo, Faris and Lätt, Jimmy and Rydelius, Anna and Englund, Elisabet and Salomonsson, Tim and Liebig, Patrick and Bengzon, Johan and van Zijl, Peter C M and Knutsson, Linda and Sundgren, Pia C},
title = {Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma},
journal = {Tomography},
year = {2025},
doi = {10.3390/tomography11060064}
}
EUVIMED